Approach Toward Diabetes Treatment in the Elderly

Area of Science:

• Geriatrics
• Endocrinology
• Pharmacology

Background:

• Elderly individuals with diabetes often have multiple comorbidities (e.g., renal failure, heart failure, cognitive impairment) complicating management.
• Hypoglycemia is a significant concern in older adults with diabetes, necessitating careful drug selection.
• Established treatment guidelines for diabetes may require modification in the elderly population.

Purpose of the Study:

• To review and recommend appropriate antidiabetic treatment strategies for elderly patients with diabetes.
• To emphasize the importance of considering comorbidities and minimizing hypoglycemia risk in this population.
• To guide the selection of oral antidiabetic agents and insulin therapy in older adults.

Main Methods:

• Review of current literature and clinical guidelines on diabetes management in the elderly.
• Analysis of the risks and benefits of various oral antidiabetic agents and insulin regimens.
• Emphasis on individualized treatment approaches based on patient-specific factors.

Main Results:

• Metformin, DPP-IV inhibitors, and SGLT2 inhibitors are recommended first-line oral agents due to lower hypoglycemia risk.
• Low-dose sulfonylureas may be used cautiously in select elderly patients.
• Newer agents like GLP-1 receptor agonists and SGLT2 inhibitors offer improved safety profiles regarding hypoglycemia and cardiovascular events.
• Individualized insulin therapy, starting with basal insulin and progressing to basal-bolus regimens if needed, is crucial.

Conclusions:

• Diabetes management in the elderly must be individualized, accounting for comorbidities and prioritizing hypoglycemia avoidance.
• Oral antidiabetic agents with a lower risk of hypoglycemia are preferred, especially in those over 75.
• Insulin therapy should be carefully titrated to prevent adverse events while ensuring glycemic control.